Abituzumab (DI17E6) is a humanized monoclonal antibody targeting Integrin alphaV, with potential anti-cancer activity. It inhibits phosphorylation of FAK, Akt, and ERK and is used in prostate cancer research.
Purity:
>95%
CAS Number:
[1105038-73-0]
Target:
Integrin
* VAT and and shipping costs not included. Errors and price changes excepted